Masayuki Ishida

Serotype-specific effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia in adults aged 65 years or older: a multicentre, prospective, test-negative design study

Motoi Suzuki, Bhim Gopal Dhoubhadel, Tomoko Ishifuji et al. · The Lancet Infectious Diseases · 2017 · 184 citations

Veterinary Medicine, Immunology, Infectious Diseases +17

A multicenter non-randomized, uncontrolled single arm trial for evaluation of the efficacy and the safety of the treatment with favipiravir for patients with severe fever with thrombocytopenia syndrome

Koichiro Suemori, Masayuki Saijo, Atsushi Yamanaka et al. · PLoS neglected tropical diseases · 2021 · 77 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Associations Between Risk Factors for Valproate Hepatotoxicity and Altered Valproate Metabolism

Tsuyoshi Kondo, Sunao Kaneko, Koichi Otani et al. · Epilepsia · 1992 · 73 citations

Pharmacy, Pharmacology, Pharmacotherapy +13

The –141C Ins/Del polymorphism in the dopamine D2 receptor gene promoter region is associated with anxiolytic and antidepressive effects during treatment with dopamine antagonists in schizophrenic patients

Akihito Suzuki, Tsuyoshi Kondo, Kazuo Mihara et al. · Pharmacogenetics · 2001 · 68 citations

Medicine, Genetics, Psychiatry +17

Effects of Various CYP2D6 Genotypes on the Steady-State Plasma Concentrations of Risperidone and Its Active Metabolite, 9-Hydroxyrisperidone, in Japanese Patients With Schizophrenia

Kazuo Mihara, Tsuyoshi Kondo, Norio Yasui‐Furukori et al. · Therapeutic Drug Monitoring · 2003 · 59 citations

Medicine, Pharmacokinetics, Pharmacology +17